LICENSE AGREEMENT (Details Narrative) - USD ($) |
3 Months Ended | ||
|---|---|---|---|
Sep. 20, 2018 |
Mar. 31, 2021 |
Sep. 30, 2018 |
|
| Research and Development Expense [Member] | |||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
| Upfront cash payment | $ 250,000 | ||
| Potential milestone payments | $ 18,400,000 | ||
| Jenrin Agreement [Member] | |||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | |||
| Upfront cash payment | $ 250,000 | ||
| Potential milestone payments | $ 18,400,000 | ||
| X | ||||||||||
- Definition Potential milestone payments. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|